Evidence map›Paper›PMID 42469845›Full record

ArticleBMC veterinary research2026

Laminaria extract reshapes the gut microbiota and TCA cycle-centered metabolic profiles associated with immune modulation in Hu lambs.

Meiqi Lin, Juanfeng Li, Jiusi Chen, Aoning Zhen, Wajiha Wajiha, Senyang Li, Xiaoying Li, Sumei Zhang, Shixun Tan, Jinfeng Zhao and 1 more

Abstract read
In one paragraph

Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Meiqi LinCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Juanfeng LiCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Jiusi ChenCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Aoning ZhenCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Wajiha WajihaCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Senyang LiCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Xiaoying LiCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Sumei ZhangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China.
Shixun TanHunan Kunbo Biotechnology Co., Ltd., Changsha, China.
Jinfeng ZhaoCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China. zhaojf0226@henau.edu.cn.
Fuchun JianCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China. jfchun2008@163.com.ORCID http://orcid.org/0000-0001-9481-2277

Funding

National Key Research and Development Program of China No. 2023YFD1801200the China Agriculture (Sheep and Goats) Research System No. CARS-38
6 · The paper itself

Abstract

backgroundThe global push to restrict antibiotic use in livestock has intensified the need for effective, safe feed additives, particularly for young lambs, which are highly susceptible to post-weaning diarrhea and immune dysfunction due to an underdeveloped intestinal barrier. Laminaria extract, rich in bioactive polysaccharides, has emerged as a promising candidate; however, its functional mechanisms in ruminants remain poorly understood. This study therefore investigated the effects of dietary Laminaria extract supplementation on growth performance, immune parameters, gut microbiota, and fecal metabolomic profiles in lambs.

methodsLambs were randomly assigned to five groups: a basal control (CON), three Laminaria extract doses (LL, 1 g/kg; LM, 3 g/kg; LH, 6 g/kg), and a diclazuril positive control (DIC). Growth performance was evaluated via body weight and average daily gain (ADG). Serum immune cytokines were measured by ELISA, gut microbiota via 16S rRNA sequencing, and fecal metabolomics by UPLC-MS, followed by integrative correlation and pathway analyses.

resultsDietary Laminaria supplementation improved growth performance and immune markers in a dose-dependent manner, with the high-dose (6 g/kg) group exhibiting the most pronounced effects. Specifically, the high-dose group showed a 217.47% increase in ADG compared with the CON group (p < 0.05). Microbiome analysis revealed a selective enrichment of beneficial genera, particularly Prevotella and Muribaculum, in the supplemented groups, with the highest relative abundances observed at the 6 g/kg dosage. Furthermore, untargeted metabolomics revealed that the high-dose group exhibited the most substantial upregulation in the relative abundances of tricarboxylic acid (TCA) cycle intermediates, with citrate and α-ketoglutarate showing 2.93-fold and 2.95-fold increases in peak intensity, respectively (p < 0.05). Concurrently, elevated relative signal intensities of short-chain fatty acids (SCFAs) were detected in the high-dose group, further supporting the metabolic benefits of Laminaria supplementation.

conclusionThis study confirmed that 3-6 g/kg dietary Laminaria extract improves growth and immunity of Hu lambs by enriching Prevotella and Muribaculum, activating TCA cycle metabolism. Low dosage prioritized antioxidant improvement, while high dosage exerted superior growth-promoting effects, supporting Laminaria extract as a natural antibiotic alternative for lambs.

Indexed as

Citric Acid CycleGastrointestinal MicrobiomeLaminariaPlant ExtractsAnimal FeedAnimalsCytokinesDietDietary SupplementsFecesMaleMetabolomeSheepCytokinesPlant ExtractsGrowth performanceGut microbiotaHu lambsImmune regulationLaminaria extractMetabolomicsTricarboxylic acid cycle

Identifiers

PMID42469845
PMCPMC13670850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.